The government on Monday approved Sputnik-V, the vaccine against the coronavirus disease (Covid-19) developed by Russia. This is the third vaccine approved by India after Covishield and Covaxin.
Dr Reddy’s Laboratories, the Hyderabad-based pharmaceutical company, last week sought the government’s approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy’s in September 2020 to conduct clinical trials of Sputnik V in India. The Russian vaccine has an efficacy of 91.6% and is conducting its Phase III clinical trials in the UAE, India, Venezuela and Belarus, according to the Sputnik-V’s website.
Along with Dr Reddy’s the RDIF partnered with Virchow Biotech Private Limited in March to produce up to 200 million doses per year of Sputnik V in India. It has also partnered with Stelis Biopharma Pvt Ltd and Panacea Biotec earlier in April as well to produce 200 million and 100 million doses per year of Sputnik V in the country.
Hits: 72
New Delhi [India], May 14: Jyotirmath, under the dynamic leadership of Present Jagadguru Shankaracharya of Jyotirmath Swamishri Avimukteshwarananda Saraswati Maharaj has appointed Mr Digant Sharma to… Read More
Ahmedabad (Gujarat) [India], May 14: Zoya by Tata, the epitome of luxury and craftsmanship, emerged as the star of Akshaya Tritiya… Read More
New Delhi [India], May 14: Products by Hafele help break barriers and facilitate the imagination of designers. This applies especially to… Read More
Mumbai (Maharashtra) [India], May 14: Today’s fast paced world has our mornings rushed, and days filled with endless tasks. A… Read More
Kolkata (West Bengal) [India], May 14: Terra, Hafele’s in-house range of premium surfaces, defines all that is “Hafele” – it… Read More
Chennai (Tamil Nadu) [India], May 14: Hafele’s Loox Range has been meeting the demands for lighting in furniture as well… Read More
This website uses cookies.